Intas Pharmaceuticals Ltd. is a vertically integrated global company, leading in the development, manufacturing and marketing of pharmaceutical formulations, including Generics, Biosimilars and Added Value Medicines. It has been growing at about 13% CAGR over the last five years and crossed the $2.5 billion mark in the past financial year. Intas is present in 85+ countries worldwide including the highly regulated markets of EU, U.S., Canada, South Africa, Australia, Asia Pacific as well as CIS & MENA regions. Intas manufactures tablets, capsules, effervescent tablets, ointments for high potency drugs, oncology orals and oncology injectables, including pre-filled syringes through fifteen formulation manufacturing facilities, of which Read more